These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28270914)

  • 1. Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis.
    Suzuki T; Suzuki Y; Okuda J; Kurazumi T; Suhara T; Ueda T; Nagata H; Morisaki H
    J Intensive Care; 2017; 5():22. PubMed ID: 28270914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bench-to-bedside review: Beta-adrenergic modulation in sepsis.
    de Montmollin E; Aboab J; Mansart A; Annane D
    Crit Care; 2009; 13(5):230. PubMed ID: 19863760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and metabolic effects of selective beta1 adrenergic blockade during sepsis.
    Gore DC; Wolfe RR
    Surgery; 2006 May; 139(5):686-94. PubMed ID: 16701103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
    Unger M; Morelli A; Singer M; Radermacher P; Rehberg S; Trimmel H; Joannidis M; Heinz G; Cerny V; Dostál P; Siebers C; Guarracino F; Pratesi F; Biancofiore G; Girardis M; Kadlecova P; Bouvet O; Zörer M; Grohmann-Izay B; Krejcy K; Klade C; Krumpl G
    Trials; 2018 Nov; 19(1):637. PubMed ID: 30454042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study.
    Brown SM; Beesley SJ; Lanspa MJ; Grissom CK; Wilson EL; Parikh SM; Sarge T; Talmor D; Banner-Goodspeed V; Novack V; Thompson BT; Shahul S;
    Pilot Feasibility Stud; 2018; 4():132. PubMed ID: 30123523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.
    Wei C; Louis H; Schmitt M; Albuisson E; Orlowski S; Levy B; Kimmoun A
    Crit Care; 2016 Dec; 20(1):407. PubMed ID: 27998289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].
    Hanss R; Bein B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):246-52; quiz 253. PubMed ID: 20387182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis and beta-blockade: a look into diastolic function.
    Astuto M
    Curr Med Res Opin; 2015; 31(10):1827-8. PubMed ID: 26211819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy.
    De Kock I; Van Daele C; Poelaert J
    Acta Clin Belg; 2010; 65(5):323-9. PubMed ID: 21128559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers in septic shock: a review.
    Vela-Vásquez RS; Grigorov-Tzenkov I; Aguilar JL
    Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):90-5. PubMed ID: 25152109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impacts of sepsis-induced myocardial dysfunction on hemodynamics, organ function and prognosis in patients with septic shock].
    Wang Z; Li H; Yao G; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Mar; 27(3):180-4. PubMed ID: 25757966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misdirected Sympathy: The Role of Sympatholysis in Sepsis and Septic Shock.
    Ferreira JA; Bissell BD
    J Intensive Care Med; 2018 Feb; 33(2):74-86. PubMed ID: 28142307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker use in severe sepsis and septic shock: a systematic review.
    Sanfilippo F; Santonocito C; Morelli A; Foex P
    Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blockers in Septic Shock].
    Uhlig C; Spieth PM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Nov; 53(11-12):787-792. PubMed ID: 30458576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock.
    Kimmoun A; Louis H; Al Kattani N; Delemazure J; Dessales N; Wei C; Marie PY; Issa K; Levy B
    Crit Care Med; 2015 Sep; 43(9):e332-40. PubMed ID: 25962080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.